NCT02392416View on ClinicalTrials.gov

Atorvastatin Study in Cardiovascular Disease Risk

CompletedOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
HypercholesterolemiaDyslipidemia
Trial Locations (2)

12462

2nd Cardiology Department,, University of Athens, Attikon Hospital

Unknown

Gennimatas General State Hospital, Athens

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY